Chronic subclinical inflammation is a key process in the pathogenesis of atherosclerotic
cardiovascular disease (ASCVD). Along with lipids, inflammation is essential for the initiation …

Endothelial dysfunction is one of the earliest manifestations of atherosclerosis, contributing
to its development and progression. Mental stress induces endothelial dysfunction through …

The control of cardiovascular risk factors, the promotion of a healthy lifestyle, and
antithrombotic therapy are the cornerstones of secondary prevention after acute coronary …

Several lines of evidence have clearly indicated that inflammation plays a pivotal role in the
development of atherosclerosis and of its thrombotic complications such as acute coronary …

Abstract Background and aims Bempedoic Acid (BA) is a novel Lipid-Lowering Therapy
(LLT). We performed a systematic review and meta-analysis to assess the efficacy and …

Colchicine is an old, inexpensive, and relatively safe anti-inflammatory drug traditionally
used in gout and over the last 50 years in familial Mediterranean fever. A search of all high …

Abstract Background and Aims Colchicine is an anti-inflammatory drug that may prevent
post-operative atrial fibrillation (POAF). The effect of this drug has been inconsistently shown …

Background Several trials have considered the safety and clinical benefits of colchicine as a
treatment option for secondary prevention in patients with coronary atherosclerotic heart …

Objective: In this study, we aimed to overview the drug interactions between colchicine and
cardiovascular drugs and performed a metaanalysis to evaluate the safety profile of …

Objective: This is the first study to explore the mechanism of colchicine in treating coronary
artery disease using network pharmacology and molecular docking technology, aiming to …